Covid today, last minute live | The presence of an antibody in the blood increases mortality from coronavirus

• Health China is the only economic power that maintains its zero Covid policy

The presence of an antibody in the blood, known as a

, increases the probability of complications and mortality from

, according to a study by the Althaia Foundation.

Lupus

is an antibody that may be present in the blood due to autoimmune diseases or an acute infection.

The study concludes that lupus anticoagulant is a predictor of hospital mortality in patients with

and that it is associated with inflammation and severity of

.

update narration

07.00.

The presence of an antibody in the blood can complicate Covid

The presence of an antibody in the blood, known as a lupus anticoagulant, increases the probability of complications and mortality from

, according to a study by the Althaia Foundation.

Lupus anticoagulant is an antibody that may be present in the blood due to autoimmune diseases or an acute infection.

The study by Dr. Mireia Constans, assistant to the Hematology Service of the Althaia Foundation in Manresa (Barcelona), aimed to study whether there was a relationship between the presence of the anticoagulant and an increase in arterial or venous thrombotic episodes and higher mortality.

The research, published in the journal "Thrombosis Research", included 211

patients who underwent the lupus anticoagulant test at the time of admission to the Althaia Foundation, in April 2020.

The test was positive in 128 patients (60.7%) and the probability of survival at 31 days was worse in the group that tested positive for lupus anticoagulant (60%) compared to the one that had tested negative (90%).

Share on Twitter

See full narration

Conforms to The Trust Project criteria

Know more

• Coronavirus

• covid 19

• Vaccines

See links of interest

• Last News

• Work calendar 2022

• The reading

• Majorca-Athletic Club